Disparities in Tobacco Product Use in the United States ANDREA GENTZKE, PHD, MS OFFICE ON SMOKING AND HEALTH CENTERS FOR DISEASE CONTROL AND PREVENTION Surveillance & Evaluation Webinar July 26, 2018
Overview Background Disparities in Tobacco Product Use among Adults, 2017 Disparities in Tobacco Product Use among Youth, 2017 Tobacco Prevention and Control Key Takeaways 2
Tobacco use is the single most preventable cause of disease, disability, and death in the U.S. 38M 480,000 Nearly 38 million U.S. adults smoked in 2016. 1 About two in every five children are exposed to secondhand smoke. 3 $300B Cigarette smoking kills about 480,000 people in the U.S. each year. 2 2 in 5 1 vs. 30 For every one smoking-related death, at least 30 people live with a serious smoking-related illness. 2 Each year, cigarette smoking costs the U.S. more than $300 billion, including $170 billion in direct medical costs and $156 billion in lost productivity. 2,4 1. Jamal A, Phillips E, Gentzke AS, et al. Current Cigarette Smoking Among Adults United States, 2016. MMWR Morb Mortal Wkly Rep 2018;67:53 59. 2. USDHHS. The Health Consequences of Smoking 50 Years of Progress: A Report of the Surgeon General, 2014. 3. Homa D, Neff L, King B, et al. Vital Signs: Disparities in Nonsmokers Exposure to Secondhand Smoke United States, 1999-2012. MMWR 2015;64(04):103-108. 4. Xu X, Bishop EE, Kennedy SM, Simpson SA, Pechacek TF. Annual healthcare spending attributable to cigarette smoking: an update. Am J Prev Med 2015; 48(3):326-33. 3
Adult per capita cigarette consumption and major smoking-and-health events U.S., 1900-2016 Sources: Adapted from Warner 1985 with permission from Massachusetts Medical Society, 1985; U.S. Department of Health and Human Services 1989; Creek et al. 1994; U.S. Department of Agriculture 2000; U.S. Census Bureau 2016; U.S. Department of the Treasury 2016. 4
Tobacco-Related Disparities Tobacco control policies have changed social norms and have led to large declines in tobacco use. Despite reductions among the general population, tobacco use is still higher among some groups. CDC s Best Practices: Differences that exist among population groups with regard to key tobacco-related indicators Patterns, prevention, and treatment of tobacco use Incidence, morbidity, mortality, and burden of tobacco-related illnesses Capacity, infrastructure, and access to resources Secondhand smoke exposure Source: CDC. Best Practices User Guide: Health Equity in Tobacco Prevention and Control. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2015. 5
The Evolving Tobacco Product Landscape Cigarettes Cigars, Cigarillos Little Cigars Smokeless Pipes Snus Tobacco Hookah Bidis Dissolvables Kreteks ENDS 6
Overview Background Tobacco Product Use among Adults, 2017 Tobacco Product Use among Youth, 2017 Tobacco Prevention and Control Key Takeaways 7
Used to assess smoking prevalence since 1965, and serves as the standard for Healthy People 2020 Is an annual, nationally representative, in-person survey of the noninstitutionalized U.S. civilian population Is a cross-sectional, annual survey of adults aged 18 years or older Consists of two parts: A set of basic health and demographic items (known as the Core questionnaire) One or more sets of questions on current health topics, including tobacco use 8
Percentage (%) Overall prevalence of tobacco product use among U.S. adults National Health Interview Survey (NHIS), 2017 25 20 19.3 16.7 15 14.0 10 5 3.8 2.8 2.1 1.0 3.7 0 Any Tobacco Product Cigarettes Cigars E-Cigarettes Smokeless Tobacco Pipe Tobacco Combustible Tobacco Product Poly Tobacco Use Source: National Health Interview Survey, 2017. Unpublished preliminary estimates. 9
Percentage (%) Who do we still need to reach? Prevalence of tobacco product use among U.S. adults, by sex National Health Interview Survey (NHIS), 2017 30 Males Females 25 24.8 20 15 14.2 15.9 12.2 10 5 0 6.8 4.0 3.3 2.4 1.8 1.0 0.2 0.4 Any Tobacco Product Cigarettes Cigars E-cigarettes Smokeless Tobacco Pipes Source: National Health Interview Survey, 2017. Unpublished preliminary estimates. 10
Percentage (%) Who do we still need to reach? Prevalence of tobacco product use among U.S. adults, by age National Health Interview Survey (NHIS), 2017 25 20 15 18.3 22.5 21.3 18-24 years 25-44 years 45-64 years 65+ years 16.1 16.5 10 11.0 10.4 8.2 5 0 5.2 4.3 4.7 3.9 3.6 2.4 1.8 2.9 2.5 2.5 2.0 1.2 0.7 0.9 0.6 0.7 Any Tobacco Product Cigarettes Cigars E-cigarettes Smokeless Tobacco Pipes Source: National Health Interview Survey, 2017. Unpublished preliminary estimates. 11
* * * * * * * * 3.3 2.2 0.9 0.6 0.7 1.1 1.4 0.6 2.2 1.8 2.8 4.0 4.3 6.0 5.8 5.6 7.2 8.9 9.9 Percentage (%) 12.7 15.2 14.9 21.4 20.1 20.6 24.0 27.4 29.8 Who do we still need to reach? Prevalence of tobacco product use among U.S. adults, by race/ethnicity National Health Interview Survey (NHIS), 2017 35 White, non-hispanic Black, non-hispanic Asian, Non-Hispanic AI/AN Hispanic non-hispanic, multi-race 30 25 20 15 10 5 0 Any Tobacco Product Cigarettes Cigars E-cigarettes Smokeless Tobacco Pipes * RSE 30% or n<50, not presented Source: National Health Interview Survey, 2017. Unpublished preliminary estimates. 12
Percentage (%) Who do we still need to reach? 25 Prevalence of tobacco product use among U.S. adults, by Census region National Health Interview Survey (NHIS), 2017 23.5 Northeast Midwest South West 20.8 20 15 15.6 15.9 16.9 15.5 10 11.2 11.0 5 0 4.9 4.1 3.2 2.8 2.9 3.1 2.8 2.9 2.0 2.2 1.3 1.7 1.4 0.6 1.0 Any Tobacco Product Cigarettes Cigars E-cigarettes Smokeless Tobacco Pipes 1.2 Source: National Health Interview Survey, 2017. Unpublished preliminary estimates. 13
* * 2.1 3.6 4.1 3.4 3.6 3.8 3.2 3.1 3.4 2.7 1.7 0.9 1.8 3.4 2.8 2.3 1.9 1.5 0.8 0.7 1.0 0.8 1.0 1.0 4.2 7.1 6.4 8.3 7.2 12.5 Percentage (%) 18.7 17.4 15.5 24.3 23.1 20.4 23.1 26.1 36.8 42.6 Who do we still need to reach? Prevalence of tobacco product use among U.S. adults, by education National Health Interview Survey (NHIS), 2017 50 45 40 0-12 years, no diploma GED High School Diploma Some College Assoc. Degree Bachelors Degree Graduate Degree 35 30 25 20 15 10 5 0 Any Tobacco Product Cigarettes Cigars E-cigarettes Smokeless Tobacco Pipes * RSE 30% or n<50, not presented Source: National Health Interview Survey, 2017. Unpublished preliminary estimates. 14
Percentage (%) Who do we still need to reach? Prevalence of tobacco product use among U.S. adults, by income National Health Interview Survey (NHIS), 2017 30 < $35,000 $35,000-$74,999 $75,000-$99,999 >= $100,000 25 20 15 26.0 20.5 18.4 13.5 21.4 15.3 11.8 10 5 0 7.6 4.4 3.6 3.7 4.0 3.6 3.1 2.5 2.6 2.8 1.8 1.6 2.0 1.4 1.0 0.8 Any Tobacco Product Cigarettes Cigars E-cigarettes Smokeless Tobacco Pipes 0.9 * RSE 30% or n<50, not presented Source: National Health Interview Survey, 2017. Unpublished preliminary estimates. 15
Percentage (%) Who do we still need to reach? Prevalence of tobacco product use among U.S. adults, by sexual orientation National Health Interview Survey (NHIS), 2017 30 27.3 Lesbian, Gay, Bisexual Heterosexual/Straight 25 20 19.1 20.3 15 13.7 10 7.5 5 0 3.8 3.8 2.6 2.1 2.1 1.0 * Any Tobacco Product Cigarettes Cigars E-cigarettes Smokeless Tobacco Pipes * RSE 30% or n<50, not presented Source: National Health Interview Survey, 2017. Unpublished preliminary estimates. 16
* 0.7 1.0 0.8 1.8 2.6 1.9 1.0 1.4 0.9 3.6 3.1 2.3 2.2 3.6 3.4 4.6 4.8 6.0 5.7 8.7 Percentage (%) 11.0 10.5 16.2 20.4 24.7 24.5 26.8 28.2 31.0 Who do we still need to reach? Prevalence of tobacco product use among U.S. adults, by health insurance National Health Interview Survey (NHIS), 2017 35 Uninsured Medicaid Other Public Insurance Private Medicare 30 25 20 15 10 5 0 Any Tobacco Product Cigarettes Cigars E-cigarettes Smokeless Tobacco Pipes * RSE 30% or n<50, not presented Source: National Health Interview Survey, 2017. Unpublished preliminary estimates. 17
Percentage (%) Who do we still need to reach? Prevalence of tobacco product use among U.S. adults, by disability/limitation status National Health Interview Survey (NHIS), 2017 30 Has a disability or limitation Does not have a disability or limitation 25 24.8 20 18.2 20.2 15 12.5 10 5 0 3.3 3.8 3.4 2.6 2.5 2.1 1.1 1.1 Any Tobacco Product Cigarettes Cigars E-cigarettes Smokeless Tobacco Pipes Disability/Limitation: Self-reported presence of impairment: vision, hearing, cognition, movement, activities of daily living, or instrumental activities of daily living. Source: National Health Interview Survey, 2017. Unpublished preliminary estimates. 18
Percentage (%) Who do we still need to reach? Prevalence of tobacco product use among U.S. adults, by serious psychological distress National Health Interview Survey (NHIS), 2017 45 40 40.8 Has serious psychological distress Does not have serious psychological distress 35 35.2 30 25 20 18.5 15 10 5 0 13.2 7.9 4.4 3.8 2.6 2.1 1.1 * * Any Tobacco Product Cigarettes Cigars E-cigarettes Smokeless Tobacco Pipes The Kessler psychological distress scale is a series of questions asking about feelings of sadness, nervousness, restlessness, worthlessness, and feeling like everything is an effort in the past 30 days. Source: National Health Interview Survey, 2017. Unpublished preliminary estimates. * RSE 30% or n<50, not presented 19
Who do we still need to reach? Any tobacco product use among U.S. adults NHIS, 2017 Race/Ethnicity Education level Annual Household Income Health insurance coverage 29.8% American Indian/Alaska Native 21.4% White 8.9% Asian 42.6% GED 8.3% Graduate degree 26.0% < $35,000 13.5% $100,000 31.0% Uninsured 28.2% Medicaid 16.2% Private Disability/limitation 24.8% Disability/limitation 18.2% No Disability/limitation Sexual orientation 27.3% Lesbian/Gay/ Bisexual 19.1% Heterosexual Serious psychological distress (SPD) 40.8% Yes SPD present 18.5% No SPD present Source: National Health Interview Survey, 2017. Unpublished preliminary estimates. 20
State Specific Estimates of E-cigarette Use among Adults, United States, 2016 Behavioral Risk Factor Surveillance System 21
Behavioral Risk Factor Surveillance System Established in 1984 in 15 states; currently collects data in all 50 states, D.C., and three U.S. Territories Objective: collect uniform state-specific data on health risk behaviors, chronic diseases and conditions, access to health care, and use of preventive health services Cross-sectional, annual survey of adults aged 18 years or older Data can be analyzed in aggregate or at the state-level or territoriallevel 22
Disparities in Smoking, by State: Adults Source: Centers for Disease Control and Prevention (CDC). State Tobacco Activities Tracking and Evaluation (STATE) System. Updated 9/2017 23
Ever E-cigarette Use Among U.S. Adults 2016 BRFSS State-Specific Data 16.2% - 19.9% 20.1% - 22.1% 22.2% - 23.8% 23.9% - 29.0% Ever e-cigarette users: Persons who reported yes to ever using an e-cigarette or other electronic vaping product, even just one time in their entire life 24
Current Cigarette Smoking Among U.S. Adult E-Cigarette Users 2016 BRFSS State-Specific Data 37.7% - 49.3% 49.4% - 55.0% 55.5% - 61.3% 61.4% - 78.1% Current e-cigarette users: Persons who reported using e-cigarettes or some other electronic vaping product some days or every day Current cigarette smokers: Persons who smoked at least 100 cigarettes in their lifetime and reported currently smoking some days or every day 25
Overview Background Tobacco Product Use among Adults, 2017 Tobacco Product Use among Youth, 2017 Tobacco Prevention and Control Key Takeaways 26
The National Youth Tobacco Survey (NYTS) Nationally representative survey of US middle and high school students Cross-sectional, school-based, self-administered U.S. public and private schools: Middle school (grades 6-8) High school (grades 9-12) 3-Stage cluster-based sampling Counties - Schools - Classes As of 2011, implemented annually in collaboration between CDC and FDA 27
Percentage (%) Prevalence of current (past 30-day) tobacco product use among U.S. middle and high school students NYTS 2017 15 High School Middle School 11.7 10 7.6 7.7 5 0 3.3 2.1 1.5 5.5 1.9 E-cigarettes Cigarettes Cigars Smokeless Tobacco 3.3 1.4 0.8 0.4 0.7 0.3 Hookah Pipe Tobacco Bidis Source: Wang T, et al. Tobacco Product Use Among Middle and High School Students United States, 2011-2017. MMWR 2018; 67(22):629-633. 28
Percentage (%) Prevalence of current (past 30-day) tobacco product use among U.S. high school students, by sex NYTS 2017 25 Males Females 21.5 20 17.5 15 13.3 10 9.9 7.6 7.5 9.0 6.3 7.7 5 0 Any Tobacco Product E-cigarettes Cigarettes Cigars Smokeless Tobacco 3.0 3.3 3.2 1.0 0.5 0.7 0.6 Hookah Pipe Tobacco Bidis Source: Wang T, et al. Tobacco Product Use Among Middle and High School Students United States, 2011-2017. MMWR 2018; 67(22):629-633. 29
Percentage (%) Prevalence of current (past 30-day) tobacco product use* among U.S. high school students, by race/ethnicity NYTS 2017 25 22.7 Non-Hispanic, White Non-Hispanic, Black Hispanic 20 16.7 15 14.2 14.2 10 5 4.9 10.1 9.5 2.8 6.2 8.4 7.8 6.7 7.2 1.8 3.7 4.6 2.8 3.1 0 Any Tobacco Product E-cigarettes Cigarettes Cigars Smokeless Tobacco Hookah * Pipe tobacco and Bidis are omitted due to statistically unreliable data (sample size <50 or relatively standard error >0.3) in stratified analyses. Non-Hispanic, Other respondents are omitted due to statistically unreliable data (sample size <50 or relative standard error >0.3) in stratified analyses. Source: Wang T, et al. Tobacco Product Use Among Middle and High School Students United States, 2011-2017. MMWR 2018; 67(22):629-633. 30
Disparities in Smoking, by State: Youth Source: Centers for Disease Control and Prevention (CDC). State Tobacco Activities Tracking and Evaluation (STATE) System. Updated 11/2017 31
Overview Background Tobacco Product Use among Adults, 2017 Tobacco Product Use among Youth, 2017 Tobacco Prevention and Control Key Takeaways 32
The Landscape is Evolving.. Internet Surveys Retail Scanner Data Social Media GIS.. So Must We. 33
Tobacco Control Vaccine Source: King, BA & Graffunder, C. The Tobacco Control Vaccine: A population-based framework for preventing tobacco-related disease and death. Tobacco Control, 2018; 27(2):123-124. 34
Comprehensive Smoke-Free Laws: United States 2000-2018 2018 35
Cigarette Excise Taxes United States 2000-2018 2000 2018 36
Tobacco Quitlines: United States 2000-2018 2018 37
National Media Campaigns: Tips, Truth, The Real Cost CDC Truth Initiative FDA 38
Takeaways 1 Tobacco use is the leading cause of preventable disease, 2 disability, and death in the United States. Cigarette smoking is down, but very large disparities in tobacco-related burdens exist across certain groups, such as AI/AN, low SES, those with mental illness, and among LGB populations. 3 4 It is important for surveillance systems to have robust sample sizes and appropriate questions to effectively assess tobacco use among these sub-populations. The sustained implementation of population-based strategies, in coordination with the regulation of tobacco products, are critical to reducing tobacco use and youth initiation. 39
Andrea Gentzke, PhD agentzke@cdc.gov Acknowledgements: Ahmed Jamal, MBBS Teresa Wang, PhD David Homa, PhD Linda Neff, PhD Office on Smoking and Health www.cdc.gov/tobacco For more information, contact CDC 1-800-CDC-INFO (232-4636) TTY: 1-888-232-6348 www.cdc.gov The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.